மேத்யூ ஹெவிட் கிரேக் மண்டபம் மூலதனம் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மேத்யூ ஹெவிட் கிரேக் மண்டபம் மூலதனம் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மேத்யூ ஹெவிட் கிரேக் மண்டபம் மூலதனம் குழு Today - Breaking & Trending Today

Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript


Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Simulations Plus, inc (NASDAQ: SLP)
Q3 2021 Earnings Call
Operator
Greetings and welcome to the Simulations Plus Third Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Brian Siegel from Hayden IR. Thank you Mr. Siegel. You may begin.SPONSORED:
10 stocks we like better than Simulations Plus, Inc.
When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , France General , North Carolina , Matt Hewitt , Raymond James , Shawn Oconnor , Walt Woltosz , Francois Brisebois , Dane Leone Raymond James , Dane Leone , Francois Brisebois Oppenheimer , Brian Siegel , Exchange Commission , Matthew Hewitt Craig Hallum Capital Group , Your Service , Simulations Plus Inc , Craig Hallum Capital Group , Simulations Plus , Motley Fool Simulations Plus , Call Transcript , Motley Fool Logo , Simulations Plus Third Quarter Fiscal , Results Conference , Motley Fool Stock Advisor , Stock Advisor , Foolish Best ,

Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript


Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Ligand Pharmaceuticals Inc (NASDAQ: LGND)
Popular Searches
Operator
Good afternoon, and thank you for standing by. Welcome to the Ligand Pharmaceuticals Quarter One Earnings Call. [Operator Instructions]. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Mr. Simon Latimer. Sir, the floor is yours.SPONSORED:
10 stocks we like better than Ligand Pharmaceuticals
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , Menlo Park , Matt Hewitt , Joseph Pantginis , Dana Flanders Guggenheim , Simon Latimer , Matt Korenberg , Matt Foehr , Balaji Prasad Barclays , John Higgins , Balaji Prasad , Jacob Johnson , Larry Solow , Alvogen Teriparitide , Scott Henry Roth , Scott Henry , Dana Flanders , Craig Hallum , Ligand Pharmaceuticals Inc , Our Pelican Expression Technology , Pelican Expression Technology , Serum Institute , Motley Fool Ligand Pharmaceuticals Inc , Cstone Pharmaceuticals , Simon Latimer Corporate Development , Ligand Pharmaceuticals ,

Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript


Simulations Plus Inc (SLP) Q2 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Simulations Plus Inc (NASDAQ: SLP)
Popular Searches
Operator
Greetings and welcome to Simulations Plus Second Quarter Fiscal 2021 Financial Results Conference Call and Webinar. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Jeff Stanlis from HAYDEN IR. Thank you. Mr. Stanlis, you may now begin.SPONSORED:
10 stocks we like better than Simulations Plus, Inc. ....

United States , France General , Matt Hewitt , David Windley , Jeff Stanlis , Paul Watkins , Shawn Oconnor , Dilisym Renasym , Francois Brisebois , David Windley Jefferies , University Of North Carolina , Simulations Plus Inc , Translational Sciences , Brazilian Health Regulatory Agency , Motley Fool Simulations Plus Inc , Toxicological Research , University Of Pittsburgh Drug Discovery Institute , Francois Brisebois Oppenheimer Co , Renasym Consortium , Institute Of Pharmaceutical Sciences , National Center , Makerere University , Department Of Pharmacology , Exchange Commission , Matthew Hewitt Craig Hallum Capital Group , Health Canada ,